Late onset Epstein-Barr virus-associated lymphoproliferative disease after allogeneic bone marrow transplant presenting as breast masses

Bone Marrow Transplantation

Volumn 21, Issue 3, 1998, Pages 295-297

  Abhyankar, S H ^a,c   Chiang, K Y ^a   McGuirk, J P ^a   Pati, A R ^a   Godder, K T ^a   Welsh, J A ^b   Waldron, R L ^c   McElveen, J L ^d   Henslee Downey, P J ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b Department of Pathology ^*  (United States)

^c Palmetto Richland Memorial Hospital   (United States)

^d South Carolina Oncology Associates   (United States)

Author keywords

Bone marrow transplant; Epstein Barr virus; Graft versus host disease; Lymphoproliferative disease

Indexed keywords

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BREAST TUMOR; CASE REPORT; CHRONIC MYELOID LEUKEMIA; EPSTEIN BARR VIRUS; FATALITY; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; LYMPHOPROLIFERATIVE DISEASE; MYCOSIS; PNEUMONIA; PRIORITY JOURNAL;

EID: 0031982582     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701070     Document Type: Article

References (10)

1. Nash RA, Pepe MS, Storb R et al. Acute graft-versus-host disease: analysis of risk factors after allogeneic bone marrow transplantation and prophylaxis with cyclosporine and methotrexate. Blood 1992; 80: 1838-1845.
2. Ho M. Risk factors and pathogenesis of post-transplant lymphoproliferative disorders. Transplant Proc 1995; 27 (Suppl 1): 38-40.
3. Bhatia S, Ramsay NKC, Steinbuch M et al. Malignant neoplasms following bone marrow transplantation. Blood 1996; 87: 3633-3639.
4. Schwartz IS, Strauchen JA. Lymphocytic mastopathy: an autoimmune disease of the breast? Am J Clin Pathol 1990; 93: 725-730.
5. Shapiro RS, McClain K, Frizzera G et al. Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation. Blood 1988; 71: 1234-1243.
6. Zutter MM, Martin PJ, Sale GE et al. Epstein-Barr virus lymphoproliferation after bone marrow transplantation. Blood 1988; 72: 520-529.
7. Newell KA, Alonso EM, Whitington PF et al. Post-transplant lymphoproliferative disease in pediatric liver transplantation. Transplantation 1996; 62: 370-375.
8. Papadopoulos EB, Ladanyi M, Emanuel D et al. Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. New Engl J Med 1994; 330: 1185-1191.
9. Smith CA, Ng CYC, Heslop HE et al. Production of genetically modified Epstein-Barr virus-specific cytotoxic T cells for adoptive transfer to patients at high risk of EBV-associated lymphoproliferative disease. J Hematother 1995; 4: 73-79.
10. O'Riordan JM, Molloy K, O'Briain DS et al. Localized, lateonset, high-grade lymphoma following bone marrow transplantation: response to combination chemotherapy. Br J Haematol 1994; 86: 183-186.